AOA Dx
Blood Test for Early Detection of Ovarian Cancer
Healthcare
Diagnostics
Women's Health
About
AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.
Founders (3)
Details
Status
Active
Stage
Early
Team Size
25
Regions
United States of America, America / Canada, Remote, Partly Remote